Have to agree with Coldchain considering GSK's move on Morphosys was on a PhaseII drug for RA. How long has PYC been persuing CD40l for RA and still no proof of concept even ?
Have to agree with Coldchain considering GSK's move on Morphosys...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
0.035(2.73%) |
Mkt cap ! $758.2M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.34 | $1.30 | $115.8K | 88.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 6466 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 3963 | 1 |
View Market Depth
| Last trade - 10.50am 07/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |